beta

CVM

Cel-Sci Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

cel-sci corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. the company's lead investigational immunotherapy is multikine, which is under phase iii clinical trial for the treatment of head and neck cancer. its ligand epitope antigen presentation system (leaps), a pre-clinical patented t-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. the company also develops leaps-h1n1-dc; cel-2000 and cel-4000 are product candidates for the treatment of rheumatoid arthritis; and leaps cov-19, a product candidate to treat covid-19 coronavirus. cel-sci corporation has a collaboration agreement with the university of georgia's center for vaccines and immunology to develop leaps covid-19 immunotherapy. the company was founded in 1983 and is headquartered in vienna, virginia.

Market Cap: 130 Million

Primary Exchange: NYSE MKT LLC

Website: http://www.cel-sci.com/

Shares Outstanding: 54 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.461505494836303

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Ethical Flags

Longest drawdown: 3181 trading days

From: 2013-04-25 To: 2024-03-07

Lowest Point:

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-10 08:51:13:000

Gainers: Provention Bio (NASDAQ: PRVB ) +296% . Vuzix Corporation (NASDAQ: VUZI ) +54% . Xynomic Pharmaceuticals Holdings (NASDAQ: XYN ) +46% . Tableau Software (NYSE: DATA ) +35% . Hi-Crush (NYSE: HCR ) +31% . Beyond Meat (NASDAQ: BYND ) +24% . Workhorse Group (NASDAQ: WKHS ) … read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-10 08:51:13:000

Gainers: Provention Bio (NASDAQ: PRVB ) +296% . Vuzix Corporation (NASDAQ: VUZI ) +54% . Xynomic Pharmaceuticals Holdings (NASDAQ: XYN ) +46% . Tableau Software (NYSE: DATA ) +35% . Hi-Crush (NYSE: HCR ) +31% . Beyond Meat (NASDAQ: BYND ) +24% . Workhorse Group (NASDAQ: WKHS ) … read more...

Microcaps dominate midday movers

via: SeekingAlpha at 2019-06-10 08:51:13:000

Gainers: Provention Bio (NASDAQ: PRVB ) +296% . Vuzix Corporation (NASDAQ: VUZI ) +54% . Xynomic Pharmaceuticals Holdings (NASDAQ: XYN ) +46% . Tableau Software (NYSE: DATA ) +35% . Hi-Crush (NYSE: HCR ) +31% . Beyond Meat (NASDAQ: BYND ) +24% . Workhorse Group (NASDAQ: WKHS ) … read more...

CEL-SCI Corporation Set to Join Russell 3000® Index

via: Business Wire at 2019-06-10 05:00:00:000

CEL-SCI Corporation (NYSE American: CVM) is set to join the broad-market Russell 3000 Index at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the US market opens on July 1, according to a preliminary list of additions posted June 7. Annual Rus… read more...

CEL-SCI Corporation Set to Join Russell 3000® Index

via: Business Wire at 2019-06-10 05:00:00:000

CEL-SCI Corporation (NYSE American: CVM) is set to join the broad-market Russell 3000 Index at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the US market opens on July 1, according to a preliminary list of additions posted June 7. Annual Rus… read more...

CEL-SCI Corporation Set to Join Russell 3000® Index

via: Business Wire at 2019-06-10 05:00:00:000

CEL-SCI Corporation (NYSE American: CVM) is set to join the broad-market Russell 3000 Index at the conclusion of the 2019 Russell indexes annual reconstitution, effective after the US market opens on July 1, according to a preliminary list of additions posted June 7. Annual Rus… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-06-15 25.0 1.0 25.0
2013-09-25 10.0 1.0 10.0
Data provided by IEX Cloud